The effects of anandamide signaling enhanced by the FAAH inhibitor URB597 on coping styles in rats

Psychopharmacology

Volumn 230, Issue 3, 2013, Pages 353-362

  Haller, Jozsef ^a   Goldberg, Steven R ^b   Pelczer, Katalin Gyimesine ^a   Aliczki, Mano ^a   Panlilio, Leigh V ^b  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Behavior; Context; Coping; Endocannabinoid; FAAH; Rats; URB597

Indexed keywords

ANANDAMIDE; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; FATTY ACID AMIDASE INHIBITOR;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BEHAVIOR CHANGE; BEHAVIOR CONTROL; CONTROLLED STUDY; COPING BEHAVIOR; DEPRESSION; EMOTIONAL DISORDER; EXPERIMENTAL TEST; LEARNING; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; TAIL PINCH TEST;

ADAPTATION, PSYCHOLOGICAL; AMIDOHYDROLASES; ANIMALS; ARACHIDONIC ACIDS; BEHAVIOR, ANIMAL; BENZAMIDES; CARBAMATES; ENDOCANNABINOIDS; MALE; MAZE LEARNING; POLYUNSATURATED ALKAMIDES; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION;

EID: 84888643879     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-013-3161-2     Document Type: Article

References (41)

1. Abush H, Akirav I (2010) Cannabinoids modulate hippocampal memory and plasticity. Hippocampus 20:1126-1138
2. Bespalov A, Kudryashova M, Zvartau E (1998) Prolongation of morphine analgesia by competitive NMDA receptor antagonist D-CPPene (SDZ EAA 494) in rats. Eur J Pharmacol 351:299-305
3. Brake WG, Flores G, Francis D, Meaney MJ, Srivastava LK, Gratton A (2000) Enhanced nucleus accumbens dopamine and plasma corticosterone stress responses in adult rats with neonatal excitotoxic lesions to the medial prefrontal cortex. Neuroscience 96:687-695
4. Campolongo P, Ratano P, Manduca A, Scattoni ML, Palmery M, Trezza V, Cuomo V (2012) The endocannabinoid transport inhibitor AM404 differentially modulates recognition memory in rats depending on environmental aversiveness. Front Behav Neurosci 6:11
5. Campolongo P, Morena M, Scaccianoce S, Trezza V, Chiarotti F, Schelling G, Cuomo V, Roozendaal B (2013) Novelty-induced emotional arousal modulates cannabinoid effects on recognition memory and adrenocortical activity. Neuropsychopharmacology. doi: 10.1038/npp.2013.26 [Epub ahead of print]
6. Cooke M, Peters E, Fannon D, Anilkumar AP, Aasen I, Kuipers E, Kumari V (2007) Insight, distress and coping styles in schizophrenia. Schizophr Res 94:12-22
7. El-Khodor BF, Boksa P (2000) Transient birth hypoxia increases behavioral responses to repeated stress in the adult rat. Behav Brain Res 107:171-175
8. Fegley D, Gaetani S, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D (2005) Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3′-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation. J Pharmacol Exp Ther 313:352-358
9. Funk D, Stewart J (1996) Role of catecholamines in the frontal cortex in the modulation of basal and stress-induced autonomic output in rats. Brain Res 741:220-229
10. Gibb J, Hayley S, Gandhi R, Poulter MO, Anisman H (2008) Synergistic and additive actions of a psychosocial stressor and endotoxin challenge: circulating and brain cytokines, plasma corticosterone and behavioral changes in mice. Brain Behav Immun 22:573-589
11. Giorgi O, Lecca D, Piras G, Driscoll P, Corda MG (2003) Dissociation between mesocortical dopamine release and fear-related behaviours in two psychokinetically selected lines of rats that differ in coping strategies to aversive conditions. Eur J Neurosci 17:2716-2726
12. Gomez FM, Ortega JE, Horrillo I, Meana JJ (2010) Relationship between non-functional masticatory activity and central dopamine in stressed rats. J Oral Rehabil 37:827-833
13. Gorzalka BB, Hill MN (2011) Putative role of endocannabinoid signaling in the etiology of depression and actions of antidepressants. Prog Neuropsychopharmacol Biol Psychiatry 35:1575-1585
14. Gunduz-Cinar O, Macpherson KP, Cinar R, Gamble-George J, Sugden K, Williams B, Godlewski G, Ramikie TS, Gorka AX, Alapafuja SO, Nikas SP, Makriyannis A, Poulton R, Patel S, Hariri AR, Caspi A, Moffitt TE, Kunos G, Holmes A (2012) Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity. Mol Psychiatry. doi: 10.1038/mp.2012.72 [Epub ahead of print]
15. Gupta AK, Gupta TK, Parmar SS, Stenberg VI (1975) Analgesic activity of substituted benzylidinohydrazines. Res Commun Chem Pathol Pharmacol 11:159-162
16. Haller J, Matyas F, Soproni K, Varga B, Barsy B, Nemeth B, Mikics E, Freund TF, Hajos N (2007) Correlated species differences in the effects of cannabinoid ligands on anxiety and on GABAergic and glutamatergic synaptic transmission. Eur J Neurosci 25:2445-2456
17. Haller J, Barna I, Barsvari B, Gyimesi Pelczer K, Yasar S, Panlilio LV, Goldberg S (2009) Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats. Psychopharmacology 204:607-616
18. Hawkins MF, Baumeister AA, Larue RH, Fountain LT, Highsmith RW, Jeffries SK, Duke MA (1999) Central GABA activation and behaviors evoked by tail-pinch stress in the rat. Physiol Behav 67:705-709
19. Kessler RC, Price RH, Wortman CB (1985) Social factors in psychopathology: stress, social support, and coping processes. Annu Rev Psychol 36:531-572
20. Kirby LG, Chou-Green JM, Davis K, Lucki I (1997) The effects of different stressors on extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid. Brain Res 760:218-230
21. Koolhaas JM (2008) Coping style and immunity in animals: making sense of individual variation. Brain Behav Immun 22:662-667
22. Koolhaas JM, Korte SM, De Boer SF, Van Der Vegt BJ, Van Reenen CG, Hopster H, De Jong IC, Ruis MA, Blokhuis HJ (1999) Coping styles in animals: current status in behavior and stress-physiology. Neurosci Biobehav Rev 23:925-935
23. Lutz B (2009) Endocannabinoid signals in the control of emotion. Curr Opin Pharmacol 9:46-52
24. Marco EM, Viveros MP (2009) The critical role of the endocannabinoid system in emotional homeostasis: avoiding excess and deficiencies. Mini-Rev Med Chem 9:1407-1415
25. Marco EM, Rapino C, Caprioli A, Borsini F, Maccarrone M, Laviola G (2011) Social encounter with a novel partner in adolescent rats: activation of the central endocannabinoid system. Behav Brain Res 220:140-145
26. Mazzola C, Medalie J, Scherma M, Panlilio LV, Solinas M, Tanda G, Drago F, Cadet JL, Goldberg SR, Yasar S (2009) Fatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-alpha nuclear receptors. Learn Mem 16:332-337
27. McLaughlin RJ, Hill MN, Bambico FR, Stuhr KL, Gobbi G, Hillard CJ, Gorzalka BB (2012) Prefrontal cortical anandamide signaling coordinates coping responses to stress through a serotonergic pathway. Eur Neuropsychopharmacol 22:664-671
28. Moreira FA, Grieb M, Lutz B (2009) Central side-effects of therapies based on CB1cannabinoid receptor agonists and antagonists: focus on anxiety and depression. Best Prac Res Clin Endocrinol Metab 23:133-144
29. Mufson EJ, Balagura S, Riss W (1976) Tail pinch-induced arousal and stimulus-bound behavior in rats with lateral hypothalamic lesions. Further evaluation of hypothalamic control of feeding and drinking. Brain Behav Evol 13:154-164
30. Naidu PS, Varvel SA, Ahn K, Cravatt BF, Martin BR, Lichtman AH (2007) Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality. Psychopharmacology 192:61-70
31. Nobrega JN, Dixon LM, Troncone LR, Barros HT (1989) Effects of chronic haloperidol on stress-induced oral behaviour in rats. Psychopharmacology 98:476-482
32. Piomelli D, Tarzia G, Duranti A, Tontini A, Mor M, Compton TR, Dasse O, Monaghan EP, Parrott JA, Putman D (2006) Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597). CNS Drug Rev 12:21-38
33. Pucheu S, Consoli S, D'Auzac C, Français P, Issad B (2004) Do health causal attributions and coping strategies act as moderators of quality of life in peritoneal dialysis patients? J Psychosom Res 56:317-322
34. Realini N, Vigano D, Guidali C, Zamberletti E, Rubino T, Parolaro D (2011) Chronic URB597 treatment at adulthood reverted most depressive-like symptoms induced by adolescent exposure to THC in female rats. Neuropharmacology 60:235-243
35. Ruehle S, Aparisi RA, Remmers F, Lutz B (2012) The endocannabinoid system in anxiety, fear memory and habituation. J Psychopharmacol 26:23-39
36. Sato M, Ishibashi S, Higashimoto M, Kadota Y, Kawakami T, Suzuki S (2011) Early changes induced by environmental stresses in insulin sensitivity-related genes. Eur J Pharmacol 668:472-476
37. 9-tetrahydrocannabinol and the fatty acid amide inhibitor URB-597 on go/no-go auditory discrimination performance and olfactory reversal learning in rats. Behav Pharmacol 22:191-202
38. Temoshok L (2000) Complex coping patterns and their role in adaptation and neuroimmunomodulation: theory, methodology, and research. Ann NY Acad Sci 917:446-455
39. Tiemensma J, Kaptein AA, Pereira AM, Smit JW, Romijn J, Biermasz NR (2011) Coping strategies in patients after treatment for functioning or nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 96:964-971
40. Westerhuis W, Zijlmans M, Fischer K, van Andel J, Leijten FS (2011) Coping style and quality of life in patients with epilepsy: a cross-sectional study. J Neurol 258:37-43
41. Zanettini C, Panlilio LV, Alicki M, Goldberg SR, Haller J, Yasar S (2011) Effects of endocannabinoid system modulation on cognitive and emotional behavior. Front Behav Neurosci 5:57